Roche therapeutic gantenerumab fails trial expectations for Alzheimer's Disease

According to the Alzheimer’s association, in 2022 approximately 6.5 million Americans are living with Alzheimer’s disease.

Related Keywords

United States ,Americans ,Sisacorn Shutterstock ,Centric Services For ,Laboratory Equipment ,Drug Processing Technology ,Processing Technology ,Cellular Immune ,Centric Services ,Alternate Site Clinical Trials ,